- - Findings from Two-Year Pivotal Phase III TEMSO Trial ...
- - First Randomized Controlled Trial to Show That Basal Plus ...
- In new guidelines from the European Society of Cardiology (ESC), prasugrel - a once daily oral ...
-Analysis evaluated efficacy and safety among three patient sub-groups A new ...
- Eli Lilly India (Lilly) and Lupin Limited (Lupin) today announced they have entered into a ...
- - Human and in vivo Studies Indicate Lantus(R) Metabolites do not ...
- Sanofi (EURONEXT: SAN and NYSE: SNY) announced today, at the 71st Scientific ...
- Jubilant Biosys Ltd., Bengaluru based subsidiary of Jubilant Life Sciences Ltd., and Endo ...
Gadjah Mada University (UGM) will hold a national seminar on the benefits, safety and development prospects of ...
- - Results of Phase III SAVE-ONCO Study Selected for "Best of ASCO 2011" ...
- Phase I Data for NKP-1339, a First-in-Class Transferrin Targeted Anti-Cancer Agent to be Presented at Upcoming ...
- Results of a new analysis from the largest-ever morbi-mortality study of ...
- Platelet Function Testing May Be Used to Aid Patient Management Accumetrics, ...
Indonesia has called on the international community to cut global demand for narcotics and drugs as part of a ...
-Evaluation of Alternative Treatment Strategies Incorporating Platelet Function Testing Recommended ...